Jupiter Neurosciences, Inc. has executed a 1-for-75 reverse stock split effective August 6, significantly reducing its outstanding shares from approximately 57.76 million to about 770,081. This move is aimed at increasing the trading price per share, which is critical for maintaining compliance with Nasdaq listing requirements.

Key Highlights

  • The new trading environment will start on August 7, marking a key moment for the stock, which faces notable downward pressure this year.
  • Shares of Jupiter Neurosciences will continue to trade under the symbol JUNS on the Nasdaq Capital Market but will have a new CUSIP number of 48208B302 post-split.
  • Jupiter Neurosciences' share price has struggled within a 52-week range of $0.07 to $1.84.

The new trading environment will start on August 7, marking a key moment for the stock, which faces notable downward pressure this year.

Trading Under New CUSIP

Shares of Jupiter Neurosciences will continue to trade under the symbol JUNS on the Nasdaq Capital Market but will have a new CUSIP number of 48208B302 post-split. The Company’s decision to perform a reverse stock split aligns with efforts to address its current stock price challenges, which have plunged by 92.4% year-to-date and 64.4% over the past month. Market capitalization now sits around $4 million, raising concerns on sustainability and investor confidence.

Financial Mechanics of the Split

The reverse stock split will automatically convert every 75 shares of common stock into one share, while no fractional shares will be issued; instead, stockholders will receive cash for any fractional entitlements based on the previous day's closing price. No reduction is planned for the total number of authorized shares, which means the overall structure remains intact. Adjustments will be made to the exercise prices of anyone holding stock options and convertible securities, which could entice new investment; however, the current pressures on share pricing remain a critical factor for investors.

Aiming for Nasdaq Compliance

Jupiter Neurosciences' share price has struggled within a 52-week range of $0.07 to $1.84. The reverse stock split is primarily a tactical move to elevate the share price above Nasdaq's minimum bid requirement for continued listing. This regulatory compliance aim reflects the company’s broader strategy to navigate current financial hurdles while maintaining listing on a major exchange.

As trading commences under the split-adjusted terms, investor focus will be on whether this adjustment can stabilize share price amidst ongoing volatility.

What’s Next for Investors

Investors will likely monitor the immediate market reaction and subsequent performance closely, assessing whether the split can revitalize investor confidence and boost shares heading into future earnings. The importance of renewing momentum after significant declines in share value sets a critical stage for management's efforts to maintain operational transparency and attract new capital.

Analysis based on the Form 8-K filed 6 August 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.